● Recruiting

Prospective, Multicenter Clinical Study of Prolonged-release Tacrolimus in Stable Pediatric Liver Transplant Recipients

Condition: Liver Transplant · Sponsor: RenJi Hospital

PhaseNA

Planned participants80

Who can joinAll sexes, 6 Months to 18 Years

Healthy volunteersNo

About this study

This study aims to explore the effects of tacrolimus sustained-release capsules on the incidence of biopsy-proven acute rejection(BPAR) and fibrosis in pediatric liver transplant recipients.

This description comes directly from the study's public registry record.

Talk to the study team

Hao Feng, MD., Ph.D · 008615000901110 · surgeonfeng@live.com

Always discuss trial participation with your own doctor first.

Locations (1)

Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University

Shanghai, China

Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06183892